72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis


Wedemeyer H., Yurdaydin C., Dalekos G., Erhardt A., Cakaloglu Y., Degertekin H., ...More

42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, Spain, 11 - 15 April 2007, vol.46 identifier